ArticleScience translational medicine2022

A prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccine.

Lauren A Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.